Rapid Micro Biosystems, Inc. (RPID)
0.92
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
Rapid Micro Biosystems Enterprise Value : 49.55M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 49.55M |
| October 01, 2026 | 49.60M |
| September 30, 2026 | 55.04M |
| September 29, 2026 | 57.54M |
| September 28, 2026 | 58.29M |
| September 25, 2026 | 59.04M |
| September 24, 2026 | 59.04M |
| September 23, 2026 | 59.04M |
| September 22, 2026 | 60.54M |
| September 21, 2026 | 60.04M |
| September 18, 2026 | 59.54M |
| September 17, 2026 | 58.04M |
| September 16, 2026 | 59.04M |
| September 15, 2026 | 61.04M |
| September 14, 2026 | 62.04M |
| September 11, 2026 | 65.04M |
| September 10, 2026 | 63.54M |
| September 09, 2026 | 64.04M |
| September 08, 2026 | 64.54M |
| September 04, 2026 | 69.03M |
| September 03, 2026 | 72.53M |
| September 02, 2026 | 73.03M |
| September 01, 2026 | 78.53M |
| August 31, 2026 | 79.53M |
| August 28, 2026 | 82.02M |
| Date | Value |
|---|---|
| August 27, 2026 | 84.02M |
| August 26, 2026 | 87.02M |
| August 25, 2026 | 86.52M |
| August 24, 2026 | 86.52M |
| August 21, 2026 | 87.52M |
| August 20, 2026 | 87.02M |
| August 19, 2026 | 88.52M |
| August 18, 2026 | 81.52M |
| August 17, 2026 | 81.02M |
| August 14, 2026 | 87.52M |
| August 13, 2026 | 88.52M |
| August 12, 2026 | 88.02M |
| August 11, 2026 | 88.02M |
| August 10, 2026 | 89.02M |
| August 07, 2026 | 90.02M |
| August 06, 2026 | 107.51M |
| August 05, 2026 | 109.01M |
| August 04, 2026 | 106.51M |
| August 03, 2026 | 109.51M |
| July 31, 2026 | 110.00M |
| July 30, 2026 | 109.01M |
| July 29, 2026 | 106.01M |
| July 28, 2026 | 106.51M |
| July 27, 2026 | 104.01M |
| July 24, 2026 | 103.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Lifecore Biomedical, Inc. | 435.86M |
| Repligen Corp. | 10.13B |
| Bio-Techne Corp. | 11.33B |
| Codexis, Inc. | 141.53M |
| MetaStat, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.92M |
| Revenue (Quarterly) | 8.054M |
| Total Expenses (Quarterly) | 20.98M |
| EPS Diluted (Quarterly) | -0.2673 |
| Gross Profit Margin (Quarterly) | 15.05% |
| Profit Margin (Quarterly) | -160.5% |
| Earnings Yield | -121.5% |
| Normalized Earnings Yield | -121.76 |